NCT07025057 Multilevel Community-Centered Intervention to Reduce Pregnancy Related and Associated Morbidity and Mortality (PRAMM) Disparities
| NCT ID | NCT07025057 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Michigan State University |
| Condition | Provider Confidence |
| Study Type | INTERVENTIONAL |
| Enrollment | 480 participants |
| Start Date | 2025-02-03 |
| Primary Completion | 2029-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 480 participants in total. It began in 2025-02-03 with a primary completion date of 2029-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the study involving human subjects is to train providers to address patient-provider interactions. The study will survey providers to assess pre-post knowledge, understanding, and behavior changes.
Eligibility Criteria
Inclusion Criteria: * Providing care to pregnant and postpartum women in Wayne, Kent, and Genesee Counties in MI Exclusion Criteria: * None
Contact & Investigator
Cristian Meghea, PhD
PRINCIPAL INVESTIGATOR
Michigan State University
Frequently Asked Questions
Who can join the NCT07025057 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Provider Confidence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07025057 currently recruiting?
Yes, NCT07025057 is actively recruiting participants. Contact the research team at overfiel@msu.edu for enrollment information.
Where is the NCT07025057 trial being conducted?
This trial is being conducted at Grand Rapids, United States.
Who is sponsoring the NCT07025057 clinical trial?
NCT07025057 is sponsored by Michigan State University. The principal investigator is Cristian Meghea, PhD at Michigan State University. The trial plans to enroll 480 participants.